Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples